<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7176985\results\search\funders\results.xml">
  <result pre="outweigh the benefits of vaccination Abstract In November 2019, The" exact="World Health Organization" post="(WHO) issued a draft set of Target Product Profiles"/>
  <result pre="of chemical mutagenesis. The vaccine is under development by the" exact="Sabin Vaccine Institute," post="Washington DC. MP-12 vaccine is conditionally licensed by the"/>
  <result pre="Centers for Disease Control and is now being developed by" exact="Colorado State University" post="and the University of California, Davis with the goal"/>
  <result pre="is now being developed by Colorado State University and the" exact="University of California," post="Davis with the goal of human testing. 2.3 Four"/>
  <result pre="not necessarily reflect the official policy or position of the" exact="Centers for Disease Control and Prevention," post="Department of the Navy, Department of Defense, nor the"/>
  <result pre="potential competing interests: Dr. Monath is a consultant to the" exact="Sabin Vaccine Institute," post="which owns the license to the MP-12 live attenuated"/>
 </snippets>
</snippetsTree>
